Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Griffiths

Showing results (1321-1330 of 1,887) with videos related to

Pageof 189
Sort By:
Trials|May 1, 2010
Protocol for a randomised controlled trial investigating the effectiveness of an online e-health application compared to attention placebo or sertraline in the treatment of generalised anxiety disorderHelen Christensen, Adam J Guastella, Andrew J Mackinnon, et al.
The British Journal of Dermatology|April 8, 2017
Identification of factors that may influence the selection of first-line biological therapy for people with psoriasis: a prospective, multicentre cohort studyN J Davison, R B Warren, K J Mason, et al.
Traffic (Copenhagen, Denmark)|February 11, 2005
Normal lytic granule secretion by cytotoxic T lymphocytes deficient in BLOC-1, -2 and -3 and myosins Va, VIIa and XVGiovanna Bossi, Sarah Booth, Richard Clark, et al.
The British Journal of Dermatology|August 3, 2006
The impact of psoriasis guidelines on appropriateness of referral from primary to secondary care: a randomized controlled trialC E M Griffiths, H Taylor, S I Collins, et al.
Journal of Crohn'S & Colitis|January 24, 2013
Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitisEytan Wine, David R Mack, Jeffrey Hyams, et al.
Respiratory Research|October 14, 2020
SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthmaMichael E Wechsler, Gene Colice, Janet M Griffiths, et al.
Respiratory Research|October 14, 2020
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthmaAndrew Menzies-Gow, Gene Colice, Janet M Griffiths, et al.
Journal of Pediatric Gastroenterology and Nutrition|April 7, 2016
Which PCDAI Version Best Reflects Intestinal Inflammation in Pediatric Crohn Disease?Dan Turner, Arie Levine, Thomas D Walters, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 22, 2019
Risk of major cardiovascular events in patients with psoriasis receiving biologic therapies: a prospective cohort studyW Rungapiromnan, K J Mason, M Lunt, et al.
Clinical and Experimental Dermatology|May 28, 2020
A skin disease and needs assessment analysis of the displaced Rohingya population in the Kutupalong refugee camp, BangladeshS S Khan, V Padovese, T A Maurer, et al.
Pageof 189

Showing results (1321-1330 of 1,887) with videos related to

Sort By:
Pageof 189
Trials|May 1, 2010
Protocol for a randomised controlled trial investigating the effectiveness of an online e-health application compared to attention placebo or sertraline in the treatment of generalised anxiety disorderHelen Christensen, Adam J Guastella, Andrew J Mackinnon, et al.
The British Journal of Dermatology|April 8, 2017
Identification of factors that may influence the selection of first-line biological therapy for people with psoriasis: a prospective, multicentre cohort studyN J Davison, R B Warren, K J Mason, et al.
Traffic (Copenhagen, Denmark)|February 11, 2005
Normal lytic granule secretion by cytotoxic T lymphocytes deficient in BLOC-1, -2 and -3 and myosins Va, VIIa and XVGiovanna Bossi, Sarah Booth, Richard Clark, et al.
The British Journal of Dermatology|August 3, 2006
The impact of psoriasis guidelines on appropriateness of referral from primary to secondary care: a randomized controlled trialC E M Griffiths, H Taylor, S I Collins, et al.
Journal of Crohn'S & Colitis|January 24, 2013
Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitisEytan Wine, David R Mack, Jeffrey Hyams, et al.
Respiratory Research|October 14, 2020
SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthmaMichael E Wechsler, Gene Colice, Janet M Griffiths, et al.
Respiratory Research|October 14, 2020
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthmaAndrew Menzies-Gow, Gene Colice, Janet M Griffiths, et al.
Journal of Pediatric Gastroenterology and Nutrition|April 7, 2016
Which PCDAI Version Best Reflects Intestinal Inflammation in Pediatric Crohn Disease?Dan Turner, Arie Levine, Thomas D Walters, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 22, 2019
Risk of major cardiovascular events in patients with psoriasis receiving biologic therapies: a prospective cohort studyW Rungapiromnan, K J Mason, M Lunt, et al.
Clinical and Experimental Dermatology|May 28, 2020
A skin disease and needs assessment analysis of the displaced Rohingya population in the Kutupalong refugee camp, BangladeshS S Khan, V Padovese, T A Maurer, et al.
Pageof 189